Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conservative treatment of non-complicated acute appendicitis in children (Latvia)
2021-001729-38Phase 4Active
- Sponsor
- Arnis Eņģelis
- Start
- Aug 2021
- Modality
- Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ceftazidime, ampicillin, amoxicillin and metronidazole in acute appendicitis, sponsored by Arnis Eņģelis. Primary endpoint: Full recovery. Started Aug 2021; status: active.
02
Drugs
ceftazidimeampicillinamoxicillinmetronidazole
03
Conditions
acute appendicitis
Beyond the preview
Go deeper on 2021-001729-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-001729-38.